Literature DB >> 15272926

Abnormal regulation of thirst and vasopressin secretion following surgery for craniopharyngioma.

D Smith1, F Finucane, J Phillips, P H Baylis, J Finucane, W Tormey, C J Thompson.   

Abstract

OBJECTIVE: In this study we aimed to establish the frequency of postoperative diabetes insipidus and the incidence and characteristics of abnormalities of thirst in a cohort of patients with craniopharyngioma, in whom neurosurgery had been performed.
DESIGN: Diabetes insipidus was determined by either standard criteria for diagnosis in the immediate postoperative period, or by water deprivation test, in all craniopharyngioma and pituitary tumour patients who underwent surgery in Beaumont Hospital between the years 1986 and 1998. Osmoregulated thirst and vasopressin release were studied during a 2-h infusion of hypertonic (5%) saline followed by a 30-min period of free access to water. PATIENTS: Data on the incidence of postoperative diabetes insipidus was collected in 26 patients with craniopharyngioma and 154 patients with pituitary adenomata. We recruited 16 healthy control patients, 16 patients with cranial diabetes insipidus following pituitary tumour surgery and 16 patients with cranial diabetes insipidus following craniopharyngioma resection for the hypertonic saline infusion study.
RESULTS: Twenty-five patients out of 26 (96%) patients developed diabetes insipidus after surgery for craniopharyngioma, a much higher incidence than after surgery for suprasellar (26/88, 30%, P < 0.001) or intrasellar pituitary tumours (9/66, 14%, P < 0.001). Hypertonic saline infusion identified abnormal thirst responses in five of the 16 craniopharygioma patients studied; all of the pituitary tumour patients had a normal thirst response. Three of the craniopharyngioma patients had adipsic diabetes insipidus whilst two had polydipsic diabetes insipidus.
CONCLUSION: This study demonstrates following surgery for craniopharyngioma there is a high incidence of cranial diabetes insipidus and a significant incidence of abnormal thirst responses to osmotic stimuli.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15272926     DOI: 10.1111/j.1365-2265.2004.02086.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  15 in total

Review 1.  Adipsic diabetes insipidus in adult patients.

Authors:  Martín Cuesta; Mark J Hannon; Christopher J Thompson
Journal:  Pituitary       Date:  2017-06       Impact factor: 4.107

2.  Adipsic diabetes insipidus in pediatric patients.

Authors:  Dominika Malgorzata Janus; Malgorzata Wojcik; Agata Zygmunt-Górska; Lukasz Wyrobek; Andrzej Urbanik; Jerzy Bogdan Starzyk
Journal:  Indian J Pediatr       Date:  2014-05-02       Impact factor: 1.967

3.  Objective assessment of thirst recovery in patients with adipsic diabetes insipidus.

Authors:  A Sinha; S Ball; A Jenkins; J Hale; T Cheetham
Journal:  Pituitary       Date:  2011-12       Impact factor: 4.107

Review 4.  Mortality and morbidity in adult craniopharyngioma.

Authors:  Eva Marie Erfurth; Helene Holmer; Sigridur Bara Fjalldal
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

5.  Practical approach to childhood craniopharyngioma: a role of an endocrinologist and a general paediatrician.

Authors:  Maria A Kalina; Eliza Skala-Zamorowska; Barbara Kalina-Faska; Ewa Malecka-Tendera; Marek Mandera
Journal:  Childs Nerv Syst       Date:  2009-06-17       Impact factor: 1.475

6.  Heterogenous patterns of recovery of thirst in adult patients with adipsic diabetes insipidus.

Authors:  M Cuesta; S Gupta; R Salehmohamed; R Dineen; M J Hannon; W Tormey; C J Thompson
Journal:  QJM       Date:  2015-09-25

7.  Hypothalamic obesity complicated by adipsic central diabetes insipidus following surgical resection of a craniopharyngioma.

Authors:  Kathleen Colleran; Leslie Sanchez-Goettler; Anita Sloan
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-10       Impact factor: 3.738

8.  Adipsic diabetes insipidus following pituitary surgery for a macroprolactinoma.

Authors:  M Sherlock; A Agha; R Crowley; D Smith; C J Thompson
Journal:  Pituitary       Date:  2006       Impact factor: 3.599

9.  Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma.

Authors:  Michael E Sughrue; Isaac Yang; Ari J Kane; Shanna Fang; Aaron J Clark; Derrick Aranda; Igor J Barani; Andrew T Parsa
Journal:  J Neurooncol       Date:  2010-06-10       Impact factor: 4.130

10.  Craniopharyngioma in adults.

Authors:  Flavius Zoicas; Christof Schöfl
Journal:  Front Endocrinol (Lausanne)       Date:  2012-03-29       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.